Skip to Main Content
Contribute Try STAT+ Today

In an unusual move, two of the world’s biggest drug makers — Bristol-Myers Squibb (BMY) and Sanofi (SNY) — filed a lawsuit accusing the Hawaii attorney general of violating their free speech rights by insisting they include certain cautionary statements about the Plavix blood thinner in product labeling.

At issue is language about the effectiveness of the medication in East Asian and Pacific Islanders, who constitute roughly half of Hawaii’s population. A lawsuit filed by the state in 2014 alleged the drug makers, which once jointly marketed the drug, failed to include data that indicated Plavix would not work for people in those groups.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.